Clinical trial
Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That…
NCT00293397 · Yale University, Other · Completed
Key facts
| NCT number | NCT00293397 |
|---|---|
| Title | Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery |
| Official title | Treatment of Patients With Hepatocellular Carcinoma Using Drug-Eluting Bead Embolization |
| Lead sponsor | Yale University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Device |
| Interventions | Drug-eluting beads loaded with doxorubicin hydrochloride |
| Enrollment | 20 |
| Start date | Nov 1, 2005 |
| Primary completion | Apr 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Feb 17, 2006 |
| Last update posted | Jul 18, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: